Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

163 results about "Chemical Injury" patented technology

Damage to body tissue caused by exposure to a chemical substance.

Application of human umbilical cord mesenchymal stem cell complex cell factor in preparing biological agent for repairing skin injury

The invention provides an application of a human umbilical cord mesenchymal stem cell complex cell factor in preparing a biological agent for repairing skin injury. The skin injury includes laser burn, thermal burn, cold injury or common trauma skin physical and chemical injury. According to the application, an umbilical cord stem cell complex growth factor is firstly used for the treatment of human skin laser injury; the human umbilical cord mesenchymal stem cell complex cell factor can be preserved in maximal activity and plays a maximal role of injury repair and treatment under a certain preservation condition.
Owner:徐妍

Sterilization composition containing dithianon and tebuconazole

The invention relates to a sterilization composition which contains the following effective ingredients in percentage by weight: 10-80% of dithianon and 70-1% of tebuconazole. Dispersing agent, wetting agent, disintegrating agent, cementing agent, thickening agent, anti-freeze agent, anti-foaming agent, and filling or deionized water are added to the composition to prepare water dispersible granules, wetting powder and suspending agent. The invention not only enlarges the anti-fungal spectrum of each effective ingredient, but also improves the biological activity of the effective ingredients. Experiments prove that the sterilization composition has better preventing and curing effects on diseases of various fruit trees and vegetables. The sterilization composition is especially suitable for preventing and curing alternaria leaf spot, leafspot, cladosporium cucumerinum and downy mildew, has no chemical injury to crops and has small pollution to environment.
Owner:SHAANXI MEIBANG PHARMA GRP CO LTD

Ophthalmic bacterial-infection resisting medicine for external use

ActiveCN101766628AGood intraocular penetrationInhibit or kill growthAntibacterial agentsSenses disorderDiseaseSide effect
The invention provides ophthalmic bacterial-infection resisting medicine for external use. Linezolid is adopted as medicative raw materials to prepare eye drops, ophthalmic gel and eye ointments. The content of the linezolid in every 100 parts by weight of a medicament is within 0.1 to 1.0 parts by weight. The medicine is for external use at partial positions of eyes, and has good intraocular penetrability and mild toxic as well as side effects; moreover, the medicine is suitable for treating as well as preventing bacterial infection at partial positions of the eyes, including diseases of conjunctivitis, keratitis, keratohelcosis, iritis, ocular traumas, chemical injuries, ophthalmic postoperative infections and the like.
Owner:GUANGDONG WHOLEWIN TECH

Acetylsalicylic acid sweetening and coloring agent and preparation method

The invention relates to a preparation for improving the color and sweet of fruits such as apple and pear, the preparation is aqueous solution agent. The red rate and sweetness of the fruit can be improved through establishing the metabolism control technology of synthesis of apple and pear color and synthesis of soluble sugar. The components and the concentration of the preparation are as follows: acetylsalicylic acid is 1.0 to 3.0 mg / L, galactose is 0.5 to 1.5 g / L, malic acid is 0.1 to 3.0 g / L, phenyalanine is 0.1 to 1.0 g / L, oxaloacetic acid is 0.1 to 1.0 g / L, boric acid is 0.1 to 2.0 g / L,monopotassium phosphate is 0.8 to 1.5 g / L, copper sulphate is 0.1 to 2.0 g / L, ammonium molybdate is 50 to 200 mg / L, twee 100 is 1.0 to 4.0 ml / L, little ethanol, and the balance water. The preparationmethod is as follows: 1, weighing up the acetylsalicylic acid, galactose, malic acid, phenyalanine, oxaloacetic acid, boric acid, monopotassium phosphate, copper sulphate, ammonium molybdate and twee100 according to a certain proportion, 2, the acetylsalicylic acid is dissolved by the ethanol, the phenyalanine is dissolved by distilled water at 100 DEG C, the monopotassium phosphate, copper sulphate and ammonium molybdate are dissolved by distilled water at 80 to 90 DEG C, other components are dissolved by distilled water at room temperature, all the components are dissolved and mixed, and then are stirred evenly to make the volume to the required volume, thereby obtaining the preparation. The preparation can improve the coloring rate of Nanguo pear by 15.8 percent. The preparation is convenient and time-saving to use, has no chemical injury and has no toxic side effect to human body and environment.
Owner:LIAONING UNIVERSITY OF PETROLEUM AND CHEMICAL TECHNOLOGY

Method for preventing or alleviating the noxious effects resulting from toxicant exposure

InactiveUS20110144137A1Reduce physical impactAvoid physical impactBiocideAnimal repellantsDiseaseIrritation
The present invention provides a method of using agents which can modulate TRPA1 function as counteragents to inhibit the physical effects of chemical irritants/toxicants when given prior to exposure or to lessen the physical effects when administered post exposure, and more specifically, to a method for counteracting the acute physical noxious effects of toxicants, including but not limited to, tear gases, chlorine, hydrogen peroxide, ammonia, phosgene, chloropicrin, isocyanates and mustard gas. Administering the counteragents counteracts pain, inflammation, lachrymation, blepharospasm, respiratory irritation and depression, airway mucus secretion, airway obstruction and injury, cough and incapacitation and cutaneous chemical injuries. Another embodiment provides a method of preventing or treating a disease or condition in a mammal, which disease or condition includes hypersensitivity to chemical stimuli, particularly in regards to inflammatory airway conditions, such as asthma, rhinitis, etc., by administering to the mammal a therapeutically effective amount of a compound that inhibits TRPA1 function, wherein the compound reduces the hypersensitivity and mediates the response to such chemical stimuli in the mammal. The invention also includes a kit containing the compound that inhibits the TRPA1 function as a counteracting agent for administration prior to or post exposure to prevent or limit the effects of the exposure.
Owner:YALE UNIV

Nuclear and chemical injury washing and cleaning device

A washing-disinfecting apparatus for the nucleochemically polluted patient is composed of a washing-disinfecting liquid tank with electric heater and liquid level sensor, an atomizing pump, a spray flow regulator, a spray-sucking unit with interfaces of defoaming agent tube and suction tube, a defoaming pump, a filter for gas-liquid separation, a vacuum turbine, a waste liquid tank, and an electric control system.
Owner:侯立安 +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products